Digital refractometer VeriLinkRx

laboratorymedical

Drug diversion testing is needed as approximately 15% of healthcare professionals struggle with drug dependence at some point in their career contributing to the drug diversion problem. Testing narcotics returned to the hospital pharmacy with the VeriLinkRx® alerts staff to tampered or sub-therapeutic dosage levels. The VeriLinkRx® can be used for possible drug diversion testing for dilutions or substitutions in Morphine, Hydromorphone, Oxycodone, Fentanyl, and other narcotics. Standard existing chain of custody control measures like biometric scanning, audit trails, passwords, and witness documentation are not sufficient to ensure that narcotics are returned to the hospital pharmacy untampered and undiluted. An analytical method, like Rudolph’s VeriLinkRx® , is a reliable and cost effective solution to verify that the actual narcotic is returned to the hospital pharmacy. Outsourced laboratory testing is too slow and expensive to test returned narcotics that are administered daily. Hand held refractometers are performance limited because their inexpensive components drift and fluctuate with temperature and sample conditions. Hand held refractometers work fine to differentiate between a 10° and 11° Brix food product, but they do not have the refractive index accuracy and temperature control stability to distinguish the Refractive Index difference between substances such as Fentanyl and water. The VeriLinkRx® was developed by Rudolph using technology predicated on rigorous pharmaceutical standards such as USP.